Valorisation of high technology radiotherapy in Europe;Valorisation de la radiothérapie de haute technologie en Europe

Cancer/Radiotherapie

Volumn 10, Issue 6-7, 2006, Pages 361-369

  Lievens, Y ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cost; High technology; Radiotherapy; Reimbursement

Indexed keywords

CANCER RADIOTHERAPY; COMPENSATION; ECONOMIC DEVELOPMENT; EUROPE; FINANCIAL MANAGEMENT; HEALTH SERVICE; ONCOLOGY; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION EQUIPMENT; REIMBURSEMENT; SHORT SURVEY; TECHNOLOGY; ARTICLE; BELGIUM; COST; ECONOMICS; HUMAN; METHODOLOGY; NEOPLASM; RADIOTHERAPY; REPRODUCIBILITY;

BELGIUM; COSTS AND COST ANALYSIS; EUROPE; HUMANS; NEOPLASMS; RADIOTHERAPY; REIMBURSEMENT MECHANISMS; REPRODUCIBILITY OF RESULTS; TECHNOLOGY;

EID: 33751025447     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.09.003     Document Type: Short Survey

References (29)

1. Aas I.H.M. Incentives and financing methods. Health Policy (New York) 34 (1995) 205-220
2. Arrêté royal modifiant l'arrêté royal du 14 septembre 1984 établissant la nomenclature des prestations de santé en matière d'assurance obligatoire soins de santé et indemnités. Le Moniteur Belge du 28 avril 2001.
3. Bentzen S.M. High-tech in radiation oncology: should there be a ceiling?. IJROBP 58 (2004) 320-330
4. Bey P. La radiothérapie conformationnelle 3D : évaluation des coûts (1999), Dans : la radiothérapie conformationelle 3D, Lille
5. Borgelt B.B., and Stone C. Ambulatory patient classifications and the regressive nature of Medicare reform: is the reduction in outpatient health care reimbursement worth the price?. Int. J. Radiat. Oncol. Biol. Phys. 45 (1999) 729-734
6. Clarke M., Collins R., Darby S., et al., Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
7. Daly-Schveitzer N., Delmas S., Bonhomme C., et al. Étude comparative des coûts réels des actes de radiothérapie et de leur valorisation par lettre clef. Cancer Radiother. 1 (1997) 314-322
8. Dunscombe P., Roberts G., and Walker J. The cost of radiotherapy as a function of the facility size and hours of operation. Br. J. Radiol. 72 (1999) 598-603
9. Ellis R.P., and McGuire T.G. Optimal payment systems for health services. J. Health Econ. 9 (1990) 375-396
10. Goitein M., and Jermann M. The relative costs of proton and X-ray radiation therapy. Clin. Oncol. 15 (2003) S37-S50
11. Hillman A.L., Pauly M.V., and Kerstein J.J. How do financial incentives affect physicians' clinical decisions and the financial performance of health maintenance organisations?. N. Engl. J. Med. 321 (1999) 86-91
12. Kesteloot K. The economics of reimbursement and technological change in cancer care. Eur. J. Cancer 31A (1995) 1406-1409
13. Kesteloot K., Pocceschi S., and van der Schueren E. Reimbursement for radiotherapy treatment in the EU countries: how to encourage efficiency, quality and access?. Radiother. Oncol. 38 (1996) 187-194
14. Kesteloot K., Lievens Y., and van der Schueren E. Improved management of radiotherapy departments through accurate cost data. Radiother. Oncol. 55 (2000) 251-262
15. Kesteloot K., Van den Bogaert W., and van der Schueren E. Bedrijfseconomische analyse van het Belgisch overheidsbeleid in de radiotherapie sinds 1991. Acta Hosp. 1 (1993) 21-38
16. Lievens Y., Van den Bogaert W., and Kesteloot K. Activity-based costing: a practical model for cost calculation in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 57 (2003) 522-535
17. Lievens Y., Van den Bogaert W., Rijders A., et al. Palliative radiotherapy practice within Western European countries: impact of the radiotherapy financing system?. Radiother. Oncol. 56 (2000) 287-293
18. Lievens Y. Cost and economic evaluation of radiotherapy. Activity-based costing and modeling techniques. Thesis submitted in fulfilment of the degree of 'Doctor in de Medische Wetenschappen. Leuven 2002.
19. Lundkvist J., Ekman M., Ericsson S.R., et al. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma. Cancer 103 (2005) 793-801
20. Lundkvist J., Ekman M., Ericsson S.R., et al. Proton therapy of cancer: potential clinical advantages and cost-effectiveness. Acta Oncol. 44 (2005) 850-861
21. Martin P. Le coût de la radiothérapie. Bull. Cancer 90 (2003) 969-975
22. Mills M.D., Spanos W.J., and Esterhay R.J. Considerations of cost-effectiveness for new radiation oncology technologies. J Am Coll Radiol 3 (2006) 278-288
23. Perez C.A., Kobeissi B., Smith B.D., et al. Cost accounting in radiation oncology: a computer-based model for reimbursement. Int. J. Radiat. Oncol. Biol. Phys. 25 (1993) 895-906
24. Pommier P., Perrier L., Auberger T., et al. Final report of the ESTRO Enlight project (European Network for LIGht Ion Hadron Therapy) (2004), Lyon, France
25. Poon I., Pintilie M., Potvin M., and McGowan T. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy. Can. J. Urol. 11 (2004) 2125-2132
26. SBU - The Swedish Council on Technology Assessment in Health Care. Acta Oncol. S6 (1996) 57-71
27. Slotman B.J., Cottier B., Bentzen S.M., Heeren G., Lievens Y., and van den Bogaert W. Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1. Radiother. Oncol. 75 (2005) 349-354
28. Van den Bogaert W. The material infrastructure of the radiotherapy departments in Belgium, Commission for material infrastructure of the Belgian Society of Radiotherapy and Oncology (BVRO-ABRO) (1983), Leuven, Belgium
29. Wodinsky H.B., and Jenkin R.D.T. The cost of radiation treatment at an Ontario regional cancer centre. Can. Med. Ass. J. 137 (1987) 906-909